Search Results - "FEHRENBACH, H"

Refine Results
  1. 1
  2. 2

    Monitoring of complement activation biomarkers and eculizumab in complement‐mediated renal disorders by Wehling, C., Amon, O., Bommer, M., Hoppe, B., Kentouche, K., Schalk, G., Weimer, R., Wiesener, M., Hohenstein, B., Tönshoff, B., Büscher, R., Fehrenbach, H., Gök, Ö.‐N., Kirschfink, M.

    Published in Clinical and experimental immunology (01-02-2017)
    “…Summary Various complement‐mediated renal disorders are treated currently with the complement inhibitor eculizumab. By blocking the cleavage of C5, this…”
    Get full text
    Journal Article
  3. 3

    IL‐37 requires IL‐18Rα and SIGIRR/IL‐1R8 to diminish allergic airway inflammation in mice by Lunding, L., Webering, S., Vock, C., Schröder, A., Raedler, D., Schaub, B., Fehrenbach, H., Wegmann, M.

    Published in Allergy (Copenhagen) (01-04-2015)
    “…Background Interleukin (IL) 37 has been described as a negative regulator of innate immunity, as it reduces the activation and cytokine production of different…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Neoalveolarisation contributes to compensatory lung growth following pneumonectomy in mice by Fehrenbach, H, Voswinckel, R, Michl, V, Mehling, T, Fehrenbach, A, Seeger, W, Nyengaard, J. R

    Published in The European respiratory journal (01-03-2008)
    “…Regeneration of the gas exchange area by induction of neoalveolarisation would greatly improve therapeutic options in destructive pulmonary diseases…”
    Get full text
    Journal Article
  6. 6

    Loss of classical transient receptor potential 6 channel reduces allergic airway response by Sel, S., Rost, B. R., Yildirim, A. Ö., Sel, B., Kalwa, H., Fehrenbach, H., Renz, H., Gudermann, T., Dietrich, A.

    Published in Clinical and experimental allergy (01-09-2008)
    “…Summary Background Non‐selective cation influx through canonical transient receptor potential channels (TRPCs) is thought to be an important event leading to…”
    Get full text
    Journal Article
  7. 7

    Animal models of pulmonary emphysema: a stereologist's perspective by Fehrenbach, H

    Published in European respiratory review (01-12-2006)
    “…CORRESPONDENCE: Dept of Internal Medicine (Respiratory Medicine), Philipps-University of Marburg, Baldingerstrasse, D-35043 Marburg, Germany. Fax: 49…”
    Get full text
    Journal Article
  8. 8

    Distal airways are protected from goblet cell metaplasia by diminished expression of IL-13 signalling components by Vock, C., Yildirim, A. Ö., Wagner, C., Schlick, S., Lunding, L. P., Lee, C. G., Elias, J. A., Fehrenbach, H., Wegmann, M.

    Published in Clinical and experimental allergy (01-09-2015)
    “…Summary Background Increased mucus production is a critical factor impairing lung function in patients suffering from bronchial asthma, the most common chronic…”
    Get full text
    Journal Article
  9. 9

    Involvement of distal airways in a chronic model of experimental asthma by Wegmann, M., Fehrenbach, H., Fehrenbach, A., Held, T., Schramm, C., Garn, H., Renz, H.

    Published in Clinical and experimental allergy (01-10-2005)
    “…Summary Background Bronchial asthma is characterized by chronic airway inflammation and airway remodelling which occurs in both proximal and distal airways…”
    Get full text
    Journal Article
  10. 10

    Asthma Update 2015--What Cell Biology in Basic Pulmonary Research Can Offer to the Pneumologist by Wegmann, M, Fehrenbach, H, Krauss-Etschmann, S

    Published in Pneumologie (Stuttgart, Germany) (01-02-2016)
    “…Bronchial asthma is one of the most common chronic inflammatory diseases world-wide causing an enormous socio-economic burden especially in industrialized…”
    Get more information
    Journal Article
  11. 11

    Up-regulated expression of the receptor for advanced glycation end products in cultured rat hepatic stellate cells during transdifferentiation to myofibroblasts by Fehrenbach, Heinz, Weiskirchen, Ralf, Kasper, Michael, Gressner, Axel M.

    Published in Hepatology (Baltimore, Md.) (01-11-2001)
    “…Receptor for advanced glycation end products (RAGE) is a member of the immunoglobulin superfamily of cell-surface molecules. Blockade of RAGE has been reported…”
    Get full text
    Journal Article
  12. 12

    Characterisation of post-pneumonectomy lung growth in adult mice by Voswinckel, R, Motejl, V, Fehrenbach, A, Wegmann, M, Mehling, T, Fehrenbach, H, Seeger, W

    Published in The European respiratory journal (01-10-2004)
    “…A model of inducible expansion of the gas exchange area in adult mice would be ideal for the investigation of molecular determinants of airspace regeneration…”
    Get full text
    Journal Article
  13. 13

    Power of Bioenergy-Related Standards to Protect Biodiversity by HENNENBERG, K. J., DRAGISIC, C., HAYE, S., HEWSON, J., SEMROC, B., SAVY, C., WIEGMANN, K., FEHRENBACH, H., FRITSCHE, U. R.

    Published in Conservation biology (01-04-2010)
    “…The sustainable production of bioenergy is vital to avoiding negative impacts on environmental goods such as climate, soil, water, and especially biodiversity…”
    Get full text
    Journal Article
  14. 14

    Keratinocyte growth factor protects against Clara cell injury induced by naphthalene by Yildirim, A. O, Veith, M, Rausch, T, Muller, B, Kilb, P, Van Winkle, L. S, Fehrenbach, H

    Published in The European respiratory journal (01-09-2008)
    “…Airway epithelial cells are exposed to environmental toxicants that result in airway injury. Naphthalene (NA) causes site-selective damage to Clara cells in…”
    Get full text
    Journal Article
  15. 15
  16. 16

    All-trans retinoic acid results in irregular repair of septa and fails to inhibit proinflammatory macrophages by SEIFART, C, MUYAL, J. P, FEHRENBACH, H, PLAGENS, A, YILDIRIM, A. Ö, KOHSE, K, GRAU, V, SANDU, S, REINKE, C, TSCHERNIG, T, VOGELMEIER, C

    Published in The European respiratory journal (01-08-2011)
    “…All-trans retinoic acid (ATRA) is controversially discussed in emphysema therapy. We re-evaluated ATRA in the elastase model and hypothesised that beneficial…”
    Get full text
    Journal Article
  17. 17

    Alveolar macrophages are the main source for tumour necrosis factor-α in patients with sarcoidosis by FEHRENBACH, H, ZISSEL, G, GOLDMANN, T, TSCHERNIG, T, VOLLMER, E, PABST, R, MÜLLER-QUERNHEIM, J

    Published in The European respiratory journal (01-03-2003)
    “…Tumour necrosis factor (TNF)-alpha is known to play a major role in the formation of noncaseating granuloma, a hallmark of sarcoidosis. The main cellular…”
    Get full text
    Journal Article
  18. 18

    Pulmonary haptoglobin and CD163 are functional immunoregulatory elements in the human lung by Abdullah, M, Kähler, D, Vock, C, Reiling, N, Kugler, C, Drömann, D, Rupp, J, Hauber, H P, Fehrenbach, H, Zabel, P, Vollmer, E, Dalhoff, K, Goldmann, T

    Published in Respiration (2012)
    “…The acute-phase protein haptoglobin (Hp) and its receptor CD163 serve as immunomodulators and possess anti-inflammatory besides antioxidant functions. To…”
    Get more information
    Journal Article
  19. 19

    Animal models of chronic obstructive pulmonary disease: some critical remarks by Fehrenbach, H

    Published in Pathobiology (Basel) (01-01-2002)
    “…A variety of animal models of chronic obstructive pulmonary disease (COPD) are available, comprising elastase instillation or inhalation of noxious agents and…”
    Get more information
    Journal Article
  20. 20